DSM Nutritional Products is pleased to confirm that RONOZYME® NP is now also officially authorized for use in sow feed in the European Union.
After intensive work by DSM scientists and regulatory experts, and a positive safety assessment by the European Food Safety Authority, approval has been granted according to Commission Regulation (EU) No 999/2010. As of 25 November 2010, the date of legal enforcement of the regulation approving RONOZYME® NP can now be sold for use in sow feed in the European Union. RONOZYME® NP is already registered for poultry, fattening pigs and piglet applications.
RONOZYME® NP is the new phytase product within the RONOZYME® feed enzyme portfolio. The new product provides an even greater release of phytate phosphorus compared to previous phytases, allowing customers to capture all the associated commercial and technical benefits.
Stéphanie Beaulieu, Category Manager Enzyme EMEA, and Arne Korsbak, Market Development Manager Phytase NSP Enzyme EMEA, comment: “This is a great achievement and will allow sow farmers to also harvest the benefits of RONOZYME® NP” “Furthermore, due leading formulation technology and better phytate phosphorus release RONOZYME® NP enables high feed cost savings of up to EUR 11–12 per ton, as well as better heat stability and superior in-feed mixability.”
The RONOZYME® product range of feed enzymes is developed within the alliance of DSM Nutritional Products and Novozymes, and represents the most complete feed enzyme portfolio within the feed industry.
About Novozymes
Novozymes is the world leader in bio innovation. Together with customers across a broad array of industries, the company creates tomorrow’s industrial bio solutions, improving its customers' business and the use of our planet's resources. With over 700 products used in 130 countries, Novozymes’ bio innovations improve industrial performance and safeguard the world’s resources by offering superior and sustainable solutions for tomorrow’s ever changing marketplace. Novozymes’ natural solutions enhance and promote everything from removing trans-fats in food, to advancing bio fuels to power the world tomorrow. Its never-ending exploration of nature’s potential is evidenced by over 4,500 patents, showing what is possible when nature and technology join forces. More than 4,500 employees working in research, production and sales around the world are committed to shaping business today and our world tomorrow. Novozymes is quoted on NASDAQ OMX Copenhagen (NZYMB). Read more at www.novozymes.com
About DSM Nutritional Products
DSM Nutritional Products is the world's leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries. The business has sales of over EUR 2 billion and a long tradition as a pioneer in the discovery of new products, new formulations and attractive applications for all industry segments. More information at www.dsmnutritionalproducts.com and www.qualityforlife.com
DSM – the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates solutions that nourish, protect and improve performance. Its end markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM manages its business with a focus on the triple bottom line of economic performance, environmental quality and social responsibility, which it pursues simultaneously and in parallel. DSM has annual net sales of about € 8 billion and employs some 22,700 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com
